ClinicalTrials.Veeva

Menu

Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments

L

Latin American Cooperative Oncology Group (LACOG)

Status

Completed

Conditions

Metastatic Breast Cancer

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT02662868
LACOG 0312

Details and patient eligibility

About

The purpose of this study is to describe demographics and socioeconomics characteristics associated to the diagnosis of metastatic breast cancer in Brazil.

Full description

The primary aim of this study is to characterize patients and treatments of metastatic breast cancer in Brazil. Other specific aims are:

to describe patients demographics and socioeconomic characteristics to describe the BC pathological characterization to describe treatment (describe each treatment with dates start-end, cycles, dosing, sequence and line of treatment, reason for discontinuation) to analyze patients outcome (time to progression, site of metastasis, progression free survival (PFS), overall survival (OS), skeletal related events (SRE))

Enrollment

767 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women > 18 years old
  • Patients diagnosed with de novo or recurrent metastatic breast cancer during the period of January to December 2012
  • Any invasive breast cancer histology and subtype

Exclusion criteria

  • Male breast cancer

Trial contacts and locations

24

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems